Are you living with Dual Diagnosis?
8 common mental disorders that exist with substance abuse disorders among dual diagnosis patients are –
* Major Depression
* PTSD or Post-Traumatic Stress Disorder
* Bipolar Disorder
* Obsessive Compulsive Disorder
* Borderline Personality Disorder
* Eating Disorders
It is important to establish an accurate diagnosis for dual diagnosis patients. The relationship between substance abuse and mental health disorders can vary in different cases.
1. Substance abuse may perpetuate, induce, worsen or alleviate psychiatric symptoms in these patients.
2. Substance abuse may cause psychiatric symptoms.
3. Acute and chronic substance use can trigger the re-emergence or worsen the severity of psychiatric disorders.
Dual diagnosis patients experience more severe and chronic medical, social and emotional dysfunction.
Since dual diagnosis patients have two disorders, they run the risk of either one worsening. Moreover, addiction relapse may cause psychiatric decompensation and worsening psychiatric problems may lead to addiction relapse. This is why relapse prevention is an integral part of dual diagnosis treatment.
Patients with dual disorders may face more crises than other patients and require longer and gradual treatment.
Dual Diagnosis Treatment
The complexity of dual diagnosis requires require an individualized treatment plan to treat patients with dual diagnosis. This is followed by a comprehensive, multidisciplinary care plan that will include treatment for both disorders.
A comprehensive treatment plan will have treatment from both addiction and mental health professionals. This has been found to be the most effective way to treat dual diagnosis patients.
Coping with a Dual Diagnosis
A few things you can do to ensure complete recovery from dual diagnosis –
* Follow your medication and psychotherapy regimen as recommended by your doctors or psychiatrist.
* Learn stress management techniques to prevent any stress, anxiety or triggers that may have been causing or sustaining the disorders.
* Observe any mood or craving patterns.
* Exercise and eat well.
* Attend both individual and group therapy.
* Reach out and ask for help if you feel you are unable to handle the pressures of a dual diagnosis. Good dual diagnosis treatment centers, such as pacific Bay Recovery in San Diego, have both inpatient and outpatient programs that can help patients find appropriate dual diagnosis treatment.
Pacific Bay Recovery offers various options for dual diagnosis treatment, such as inpatient and intensive outpatient programs. To learn more about dual diagnosis treatment in San Diego, call the top drug detox and addiction treatment centers in San Diego, Pacific Bay Recovery at 858-263-9700 Today.
Pacific Bay Recovery
1501 5th Avenue, Suite 100
San Diego, CA 92101
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Are you living with Dual Diagnosis? here
News-ID: 879628 • Views: 608
More Releases from Pacific Bay Recovery
Inpatient vs. Outpatient Treatment: Which one is right for you?
Inpatient residential and outpatient rehab are the two most commonly offered addiction treatment options. But how do you pick the one that is right for you? The Need for Drug Rehab Addiction is a progressive disease that makes the user unable to abstain from drugs and alcohol. This could be accompanied by impaired emotional and behavioral control, cravings and denial. Like many other chronic diseases, addiction often involves relapse. Without treatment or
Treatment Options for Addicted Youth
Adolescence is a time of self-discovery and experimentation and unfortunately for most teens, this means experimenting with alcohol and drugs. While some teens don’t end up addicted after their first few encounters, plenty of others do… leading to a lifelong struggle. Common Substance Addictions in Teens • Marijuana or weed is extremely popular among teens. Most teens don’t consider marijuana as addictive or harmful. • Alcohol is the most readily available and
The Importance of Detox in Recovery
The long-term alcohol or drug abuse leads to physical dependence. When you try to stop taking these substances, it would lead to acute withdrawal symptoms. This is why detoxification is extremely important. Drug detox is especially designed to rid the body of the substance and treat the physical effects of withdrawal. It is a systematic process conducted under medical supervision and is followed by a complete recovery process. For someone who is
5 Signs your Employee uses Drugs
Employees are an organization’s most valuable asset and resource. If an employee is struggling with addiction, it can have a big impact on how your organization functions. Apart from costing you time and money, it may be counterproductive to the overall functioning of your organization. This is why you should be aware of the signs of employee drug use within the organization. It will enable you to help an employee
More Releases for Disorder
Anti-Depressant Drugs Market to 2027 - Global Analysis and Forecasts By Depressi …
Anti-depressant drugs is a class of medications which is used to treat major depressive disorder, some anxiety disorders, some chronic pain conditions, and to help manage some addictions. Anti-depressant drugs also reduce symptoms of depressive disorders by correcting chemical imbalances of neurotransmitters in the brain. Chemical imbalances may be responsible for changes in mood and behavior. Anti-depressant drugs market is anticipated to grow in the forecast period owing to driving factors
Antidepressant Drugs Market Report 2018: Segmentation by Depressive Disorder (Ma …
Global Antidepressant Drugs market research report provides company profile for Alkermes Plc, Allergan Plc, Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms
Autism Spectrum Disorder (ASD) Treatment Market Report 2018: Segmentation by Aut …
Global Autism Spectrum Disorder (ASD) Treatment market research report provides company profile for Roche Pharmaceuticals, Autism Treatment Plus, Fraser, Retrophin, Inc., Autism Services Inc., Pfizer Inc., SynapDx, Behavior Analysis, Inc., Autism Therapeutics, Curemark LLC and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate,
Speech Therapy Service Market Report 2018: Segmentation by Product (Speech Disor …
Global Speech Therapy Service market research report provides company profile for Benchmark Therapies, Talk Speech, Language Therapy, Speech Plus, Smart Speech Therapy, Therapy Solutions, Glenda Browne Speech Pathology and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018
Somatostatin Receptor Market For Hormonal Disorder, Oncology, Metabolic Disorder
MarketResearchReports.Biz adds “Global Somatostatin Receptor Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Somatostatin Receptor and the growth estimates for the forecasted period. This report studies the Somatostatin Receptor Type 2 market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global
Thyroid Gland Disorder Treatment Market: Increasing incidence of Autoimmune Dise …
The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of